Clinical trial

Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer

NCT00685633

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE2

Study timeline

Study start (unknown)2008-12-01Date precision: month

Registry last updated2013-08-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

bicalutamideDRUG · verified · RxNorm: bicalutamide

enzastaurin hydrochlorideDRUG

Sponsors & collaborators

Eastern Cooperative Oncology Grouplead sponsor

National Cancer Institute (NCI)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00685633 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.